Exosome Enzymatic Activity Assays

Q: How do you distinguish vesicle-associated enzyme activity from free enzyme contamination?

Every assay includes three controls run in parallel: native intact vesicles, heat-inactivated vesicles (95°C for 10 minutes), and vesicle-depleted supernatant (filtered through 0.22 µm after ultracentrifugation). Genuine vesicle-associated activity should be abolished by heat inactivation and absent in the depleted supernatant. If more than 10% of total activity appears in the supernatant control, we flag the preparation for potential free-enzyme contamination.

Q: What enzyme classes can you measure in microbial vesicles?

Our standard panel covers serine proteases, metalloproteases, DNases, RNases, alkaline phosphatases, acid phosphatases, esterases, and beta-lactamases. For engineered vesicles carrying non-native enzymes (luciferase, peroxidase, therapeutic enzymes), we develop custom assays with client-specified substrates and reaction conditions.

Q: Can you measure enzymatic activity in vesicles from Gram-positive bacteria?

Yes. Our protocols accommodate both Gram-negative outer membrane vesicles (OMVs) and Gram-positive cytoplasmic membrane vesicles (CMVs) from probiotic species such as Lactobacillus and Bifidobacterium. We adjust buffer conditions and substrate concentrations to account for differences in membrane composition and enzyme accessibility.

Q: How much vesicle material do I need to provide?

For a single enzyme class assay, 100–200 µL of purified vesicle suspension is typically sufficient. Multi-enzyme panels require 300–500 µL, and custom assay development may need up to 1 mL. We recommend shipping aliquoted samples to avoid freeze-thaw degradation when multiple assays are planned.

Q: Can enzymatic activity data be used as a batch release criterion?

Yes. Enzymatic activity is an excellent functional potency marker for batch consistency. We can establish acceptance criteria based on historical batch data and provide CoA-compatible reports for clients developing Food-Grade or GMP-Grade vesicle products. Typical release criteria include activity within ±20% of the reference batch value.

Q: Do you offer kinetic or endpoint readouts?

Both. Kinetic readouts provide reaction velocity (V0) and are preferred for enzymes with rapid substrate turnover, such as beta-lactamases and proteases. Endpoint readouts are suitable for slow reactions or when high-throughput screening across many samples is needed. We recommend kinetic measurements for publication-quality data.

Q: Can you correlate enzymatic activity with vesicle characterization data?

Yes. We can integrate enzymatic activity results with NTA particle counts, protein concentration, and zeta potential data from our Exosome Characterization & Quality Analytics services. This correlation helps identify whether activity differences stem from particle yield, cargo density, or vesicle integrity variations.

Q: What happens if my vesicle preparation shows no detectable enzymatic activity?

Low or undetectable activity may indicate enzyme degradation during preparation, low cargo loading, or the absence of the target enzyme in your vesicle cargo. We provide a diagnostic report including control data and recommendations, which may include proteomics analysis to confirm enzyme presence or protocol adjustments to preserve enzyme integrity during isolation.

Inquiry

OverviewServicesSamplesAdvantagesApplicationsCase StudyFAQs

Overview

Measuring enzymatic activity within microbial extracellular vesicles (mEVs) provides a direct functional readout that particle counts and protein concentrations alone cannot deliver. A vesicle preparation may contain billions of particles, yet only a fraction may carry catalytically competent enzymes—the very cargo that determines whether the preparation will degrade a target substrate, modulate a signaling pathway, or resist an antibiotic in the recipient environment.

At Creative BioMart Microbe, we have built a dedicated enzymatic activity assay platform for bacterial and probiotic extracellular vesicles, covering proteases, nucleases, phosphatases, esterases, beta-lactamases, and custom enzyme cargos. Each assay is paired with appropriate substrate controls, heat-inactivated references, and protein-normalized activity calculations so that results reflect genuine vesicle-associated catalysis rather than co-purified free enzyme. Our protocols accommodate both Gram-negative outer membrane vesicles (OMVs) and Gram-positive cytoplasmic membrane vesicles (CMVs), and integrate with our Exosome Characterization & Quality Analytics pipeline for full physicochemical correlation.

Whether you need to demonstrate that an engineered strain secretes functional enzyme-loaded vesicles, benchmark potency across production batches, or generate release criteria for Food-Grade or GMP-Grade material, our enzymatic assay data deliver the quantitative evidence required. Contact us to discuss your mEV enzymatic activity profiling project.

Scientific workflow diagram showing five stages of exosome enzymatic activity assay service: sample consultation, vesicle preparation and normalization, substrate-specific enzymatic reaction, quantitative activity readout, and comparative analysis reporting, with each stage containing detailed laboratory illustrations.
Figure 1. End-to-end workflow for microbial exosome enzymatic activity assays, from sample intake through normalized activity quantification to comparative potency reporting.

Services

Service Workflow

Our enzymatic activity assay workflow follows a structured five-step process designed to isolate genuine vesicle-associated catalysis from background noise. Each step incorporates controls and normalization strategies that ensure the final activity values are attributable to intact vesicle-carried enzymes, not free contaminants.

Horizontal process flowchart showing five steps for exosome enzymatic activity assays: sample intake and characterization, vesicle integrity verification, substrate-specific enzyme reaction, kinetic and endpoint activity quantification, and comparative analysis and reporting.

Inquiry

Service Details

3D illustration of a multi-well plate with protease substrate cleavage reaction, fluorescent product formation, and a protease enzyme molecule on a vesicle membrane surface.

Protease Activity Profiling

We quantify vesicle-associated protease activity using fluorescent casein, gelatin, and peptide-MCA substrates that release measurable signal upon cleavage. Kinetic and endpoint readouts distinguish metalloproteases, serine proteases, and aspartic proteases through selective inhibitor panels. Clients receive specific activity values normalized to vesicle protein and particle number.

3D illustration of a DNA double helix substrate being cleaved by a nuclease enzyme carried on a bacterial vesicle surface, with fluorescent cleavage fragments visible in solution.

Nuclease Activity Assessment

We measure DNase and RNase activities associated with microbial vesicles using fluorometric substrate assays with labeled nucleic acid probes. Activity is reported as degradation rate per microgram of vesicle protein, with controls including heat-inactivated vesicles and vesicle-depleted supernatant to confirm vesicle-bound catalysis.

3D illustration of a chromogenic phosphatase substrate reaction in a cuvette, showing color change from substrate cleavage by vesicle-associated alkaline phosphatase enzyme.

Phosphatase & Esterase Activity

Our platform quantifies alkaline phosphatase, acid phosphatase, and esterase activities using chromogenic p-nitrophenyl substrates and fluorogenic coumarin derivatives. These enzymes serve as both functional cargo reporters and vesicle integrity markers, as their activity confirms that luminal enzymes remain folded and accessible.

3D illustration of a beta-lactam antibiotic molecule being degraded by a beta-lactamase enzyme displayed on the surface of a bacterial outer membrane vesicle.

Beta-Lactamase & Resistance Enzyme Assays

We assess antibiotic-degrading enzyme activity in OMV preparations using nitrocefin chromogenic assays and kinetic spectrophotometric readouts. This service is particularly relevant for studies on horizontal resistance transfer, where vesicle-mediated beta-lactamase sharing protects susceptible bacterial populations.

3D illustration of a modular assay design concept showing interchangeable enzyme-substrate reaction chambers connected to a central vesicle sample source.

Custom Enzyme Activity Assays

For engineered mEVs carrying non-native enzymes—such as luciferase reporters, peroxidase fusions, or therapeutic enzyme cargos—we develop custom activity assays tailored to the specific substrate and reaction conditions. Method development includes buffer optimization, linearity validation, and interference testing.

Assay Capabilities & Specifications

Enzyme Class & Substrate Panel

Enzyme Class	Substrate / Method	Readout Mode
Serine protease	Fluorescent casein, Suc-AAPF-MCA	Fluorescence (kinetic)
Metalloprotease	Gelatin-FITC, DQ-gelatin	Fluorescence (kinetic)
DNase / RNase	FRET-labeled DNA/RNA probes	Fluorescence (endpoint & kinetic)
Alkaline phosphatase	p-Nitrophenyl phosphate	Absorbance 405 nm
Esterase	Coumarin derivatives, p-NPA	Fluorescence / absorbance
Beta-lactamase	Nitrocefin, CENTA	Absorbance 490–495 nm (kinetic)
Custom / engineered	Client-specified substrate	Method-dependent

Typical Data Range

Protease specific activity: 0.5–50 mU/mg vesicle protein (strain and enzyme dependent).
Nuclease degradation rate: 5–80% substrate conversion per 10 µg vesicle protein per hour.
Alkaline phosphatase activity: 2–30 mU/mg for E. coli OMV preparations.
Beta-lactamase activity: 10–50 mU/mg for resistant-strain OMVs; <1 mU/mg for susceptible controls.
Intra-assay CV ≤ 12%; inter-assay CV ≤ 18% for all enzymatic readouts.
Heat-inactivated control activity: <5% of native vesicle activity (confirms enzyme-dependent signal).
Vesicle-depleted supernatant control: <10% of intact vesicle activity (confirms vesicle association).

Turnaround Time

Service Type	Timeline
Single enzyme class assay (one vesicle preparation)	1–2 weeks
Multi-enzyme panel (3+ enzyme classes, one preparation)	2–3 weeks
Comparative batch analysis (3+ preparations, one enzyme class)	2–3 weeks
Custom enzyme assay development	3–5 weeks
Comprehensive potency package (multi-enzyme + physicochemical characterization)	4–6 weeks
Expedited timeline	+50% fee, 40% time reduction

Timeline may vary based on enzyme class number, vesicle preparation count, and custom assay development requirements.

Deliverables

Activity report: Raw kinetic/endpoint data, calculated specific activity (mU/mg protein and mU/10¹⁰ particles), and normalized comparison tables.
Control data: Heat-inactivated, vesicle-depleted supernatant, and substrate-only baseline controls for every assay.
Inhibitor profiling: Enzyme class identification results based on selective inhibitor sensitivity (where applicable).
Batch comparison: Statistical comparison across preparations with fold-change and significance testing.
Method summary: Buffer composition, substrate concentration, reaction time, and instrument settings for reproducibility.

Quality Control

Vesicle integrity pre-check: NTA size and concentration confirmation before enzymatic assay setup.
Protein normalization: BCA or Bradford assay on every preparation; activity expressed per microgram protein and per particle.
Linearity validation: Enzyme activity confirmed within the linear range of the detection method for each substrate.
Control panel: Native vesicles, heat-inactivated (95°C, 10 min), vesicle-depleted supernatant, and free enzyme standard run in parallel.
Intra-assay CV ≤ 12%; inter-assay CV ≤ 18% for all quantitative endpoints.
Documentation trail: Full instrument raw data retained for audit and regulatory submissions.

Sample Requirements

Required Information	Optional Information	Not Accepted
Vesicle source organism (species and strain) Vesicle type (OMV, CMV, or mixed) Target enzyme class(es) of interest Vesicle preparation method used Particle concentration and protein content (if available) Intended application (research, batch release, regulatory)	Prior NTA or DLS characterization data Known enzyme cargo (from proteomics or cargo analysis) Specific substrate preference Reference enzyme standard for benchmarking Expected activity range or literature reference Desired readout format (kinetic, endpoint, or both)	Crumbled or aggregated vesicle suspensions without size data Preparations with visible precipitates or turbidity Samples in buffers incompatible with enzymatic assay (e.g., high detergent) Fixative-treated or chemically cross-linked vesicles Mixed-species vesicle preparations without source identification Samples shipped without cold-chain documentation

Recommended Sample Quantity by Assay Type:

Assay Type	Minimum	Recommended
Single enzyme class assay	100 µL purified vesicles	200–500 µL
Multi-enzyme panel (3+ classes)	300 µL purified vesicles	500–1,000 µL
Comparative batch analysis (per batch)	100 µL per preparation	200 µL per preparation
Custom assay development	500 µL purified vesicles	1 mL purified vesicles
Comprehensive potency package	500 µL purified vesicles	1–2 mL purified vesicles

Storage & Shipping: Ship purified vesicle suspensions on dry ice in sterile PBS or compatible buffer. Include particle concentration data and any prior characterization results. For custom enzyme assays, provide the target substrate and any reference enzyme if available. Avoid repeated freeze-thaw cycles; aliquot samples before shipping if multiple assays are planned.

Inquiry

Our Advantages

Vesicle-Association Verification — Heat-inactivated and vesicle-depleted supernatant controls ensure measured activity reflects genuine vesicle-carried enzymes, not co-purified free protein.
Broad Enzyme Class Coverage — Substrate library spans proteases, nucleases, phosphatases, esterases, and beta-lactamases, with custom assays for engineered cargos.
Dual Normalization Strategy — Activity reported per microgram protein and per 10¹⁰ particles, enabling cross-preparation comparisons by cargo density and yield.
Microbial-Native Protocols — Methods optimized for bacterial OMV and probiotic CMV membrane composition, cargo complexity, and enzyme profiles.
Regulatory-Ready Documentation — Full raw data, calibration records, and control documentation support Application-Grade batch release and regulatory submissions.

Applications

3D illustration of a vesicle preparation being analyzed for enzymatic potency, showing a bar chart comparison of activity levels across different vesicle batches.

Potency Biomarker Discovery

Enzyme activity as a quantitative potency marker for identifying high-function vesicle-producing strains.

3D illustration of a quality control checkpoint with a vesicle sample vial passing through an enzymatic activity gate, shown with a green checkmark approval indicator.

Batch Release Testing

Enzymatic activity thresholds as release criteria for consistent vesicle product manufacturing.

3D illustration of multiple bacterial strain silhouettes arranged in a grid, each producing vesicles with different enzymatic activity levels shown as varying color intensity.

Strain & Batch Comparison

Side-by-side enzymatic profiling to rank strains or production batches by functional cargo output.

3D illustration of an engineered vesicle with a highlighted enzyme cargo molecule inside, shown with a fluorescent signal indicating successful catalytic function.

Engineered Cargo Validation

Confirming that genetically loaded enzyme cargos retain catalytic activity within vesicle lumen or surface.

Case Study

Case Study 1: Beta-Lactamase Activity in E. coli OMVs Confers Antibiotic Protection

Investigators compared beta-lactamase activity in OMVs from beta-lactam-resistant (E. coli RC85+) and susceptible (RC85) strains. Kinetic spectrophotometric assays using nitrocefin substrate revealed that RC85+ OMVs exhibited specific activity of 47.9 mU/mg protein—a 3.1-fold increase over susceptible-strain OMVs. When susceptible RC85 cells were co-cultured with RC85+ OMVs in the presence of lethal antibiotic concentrations, bacterial survival was restored. Addition of beta-lactamase inhibitors (clavulanic acid or sulbactam) abolished this protective effect, confirming that the protective effect was entirely enzyme-dependent. This study demonstrates how quantitative enzymatic activity measurement in OMVs can predict functional outcomes in microbial communities.

Bar chart and kinetic curves showing beta-lactamase activity differences between OMVs from resistant and susceptible E. coli strains, measured by absorbance at 490 nm over time and normalized per milligram of protein.
Figure 2. Investigation of the differences in β-lactamase activity between cell extracts, culture supernatant, and OMVs from RC85+ and RC85 cells. (Kim, et al. 2018)

FAQs

Q: How do you distinguish vesicle-associated enzyme activity from free enzyme contamination?

A: Every assay includes three controls run in parallel: native intact vesicles, heat-inactivated vesicles (95°C for 10 minutes), and vesicle-depleted supernatant (filtered through 0.22 µm after ultracentrifugation). Genuine vesicle-associated activity should be abolished by heat inactivation and absent in the depleted supernatant. If more than 10% of total activity appears in the supernatant control, we flag the preparation for potential free-enzyme contamination.

Q: What enzyme classes can you measure in microbial vesicles?

A: Our standard panel covers serine proteases, metalloproteases, DNases, RNases, alkaline phosphatases, acid phosphatases, esterases, and beta-lactamases. For engineered vesicles carrying non-native enzymes (luciferase, peroxidase, therapeutic enzymes), we develop custom assays with client-specified substrates and reaction conditions.

Q: Can you measure enzymatic activity in vesicles from Gram-positive bacteria?

A: Yes. Our protocols accommodate both Gram-negative outer membrane vesicles (OMVs) and Gram-positive cytoplasmic membrane vesicles (CMVs) from probiotic species such as Lactobacillus and Bifidobacterium. We adjust buffer conditions and substrate concentrations to account for differences in membrane composition and enzyme accessibility.

Q: How much vesicle material do I need to provide?

A: For a single enzyme class assay, 100–200 µL of purified vesicle suspension is typically sufficient. Multi-enzyme panels require 300–500 µL, and custom assay development may need up to 1 mL. We recommend shipping aliquoted samples to avoid freeze-thaw degradation when multiple assays are planned.

Q: Can enzymatic activity data be used as a batch release criterion?

A: Yes. Enzymatic activity is an excellent functional potency marker for batch consistency. We can establish acceptance criteria based on historical batch data and provide CoA-compatible reports for clients developing Food-Grade or GMP-Grade vesicle products. Typical release criteria include activity within ±20% of the reference batch value.

Q: Do you offer kinetic or endpoint readouts?

A: Both. Kinetic readouts provide reaction velocity (V₀) and are preferred for enzymes with rapid substrate turnover, such as beta-lactamases and proteases. Endpoint readouts are suitable for slow reactions or when high-throughput screening across many samples is needed. We recommend kinetic measurements for publication-quality data.

Q: Can you correlate enzymatic activity with vesicle characterization data?

A: Yes. We can integrate enzymatic activity results with NTA particle counts, protein concentration, and zeta potential data from our Exosome Characterization & Quality Analytics services. This correlation helps identify whether activity differences stem from particle yield, cargo density, or vesicle integrity variations.

Q: What happens if my vesicle preparation shows no detectable enzymatic activity?

A: Low or undetectable activity may indicate enzyme degradation during preparation, low cargo loading, or the absence of the target enzyme in your vesicle cargo. We provide a diagnostic report including control data and recommendations, which may include proteomics analysis to confirm enzyme presence or protocol adjustments to preserve enzyme integrity during isolation.

References:

Kim, S. W., et al. (2018). Outer membrane vesicles from β-lactam-resistant Escherichia coli enable the survival of β-lactam-susceptible E. coli in the presence of β-lactam antibiotics. Scientific Reports, 8, 6070.

Services

Inquiry